Welcome to our dedicated page for AdaptHealth news (Ticker: AHCO), a resource for investors and traders seeking the latest updates and insights on AdaptHealth stock.
AdaptHealth Corp. (NASDAQ: AHCO) is a leading provider of patient-centered, healthcare-at-home solutions across the United States. Operating in 47 states, AdaptHealth offers a comprehensive range of home medical equipment (HME) and services to help patients manage chronic conditions and improve their quality of life in the comfort of their homes.
Founded on the principle that everyone deserves a comfortable and independent life, AdaptHealth's offerings include sleep and respiratory therapy, diabetes management supplies, mobility products, wound care, non-invasive ventilation, and nutritional support. Their clinically-focused services assist patients with daily living activities, supporting approximately 4.1 million patients annually through a network of around 670 locations.
The company's core offerings include sleep therapy equipment (including CPAP and biPAP services) for those with obstructive sleep apnea, medical devices for diabetes management (such as continuous glucose monitors and insulin pumps), and oxygen therapy and related chronic care services. Additionally, AdaptHealth provides specialized HME devices and supplies for wound care, urological, incontinence, ostomy, and nutritional needs.
AdaptHealth is renowned for its extensive partnerships with a diverse network of referral sources, including acute care hospitals, sleep labs, pulmonologists, skilled nursing facilities, and clinics. The company serves beneficiaries of Medicare, Medicaid, and commercial insurance payors, making it a cornerstone in the provision of at-home medical care in the U.S.
Despite facing challenges, AdaptHealth has shown remarkable financial resilience and growth. The company reported a net revenue of $793.3 million for the second quarter of 2023, an increase of 9% compared to the same period in 2022. Their adjusted EBITDA reached $171.0 million, up by 14%, showcasing robust financial health and operational efficiency.
Going forward, AdaptHealth continues to focus on enhancing its service offerings and operational efficiency under new leadership. The recent appointment of Suzanne Foster as Chief Executive Officer marks a significant step in the company’s strategic direction, aimed at furthering its mission to deliver high-quality, patient-centered care.
For more detailed financial results and updates, visit AdaptHealth’s official website.
AdaptHealth Corp. (NASDAQ: AHCO) announced it will release its financial results for Q1 2021 on May 6, 2021, prior to market opening. A conference call is scheduled for the same day at 8:30 am ET to discuss the results. The company specializes in providing patient-centric, technology-enabled chronic disease management, serving nearly 3 million patients annually across 500+ locations in 46 states. The offerings include sleep therapy equipment, diabetes management products, home medical equipment, and chronic therapy services.
AdaptHealth Corp. (NASDAQ: AHCO) has announced that Co-CEO Luke McGee has been charged with tax fraud related to personal conduct from March 2014 to August 2015, unrelated to the company's operations. McGee is on unpaid leave pending the outcome. The Board expresses full confidence in the management team led by Co-CEO Steve Griggs and President Josh Parnes to uphold business strength and growth. AdaptHealth provides home healthcare solutions nationwide, serving approximately 1.8 million patients annually across its 269 locations.
AdaptHealth Corp. (NASDAQ: AHCO) reported strong financial results for Q4 and FY 2020. Q4 net revenue reached $348.4 million, a 133% increase year-over-year, while FY revenue hit $1.06 billion, up 99%. However, the company experienced a net loss of $31.0 million in Q4 and $64.5 million for the full year, primarily due to non-cash charges. AdaptHealth has closed the acquisition of AeroCare and anticipates $50 million in annual cost synergies. The company raised its 2021 guidance, projecting net revenue of $2.18 to $2.35 billion.
AdaptHealth Corp. (NASDAQ: AHCO), a top provider of home medical equipment in the U.S., announced that its Co-CEOs, Luke McGee and Steve Griggs, along with CFO Jason Clemens, will present at two upcoming investor conferences.
- SVB Leerink 10th Annual Global Healthcare Conference on February 25, 2021, at 3:00 p.m. ET.
- J.P. Morgan Global High Yield & Leveraged Finance Conference on March 3, 2021, at 11:30 a.m. ET.
Live webcasts will be available on AdaptHealth’s website. The company serves nearly 3 million patients annually through a network of over 500 locations across 46 states.
AdaptHealth Corp. (NASDAQ: AHCO) will announce its financial results for Q4 and full year 2020 on March 4, 2021, before market opening. A conference call is scheduled for 8:30 am ET that same day to discuss the results and business activities. Interested parties can join by calling either (877) 423-9820 (Domestic) or (201) 493-6749 (International). After the call, a replay will be available on the Company’s website for six months under 'Investor Relations.'
AeroCare Holdings has been acquired by AdaptHealth Corp. in a deal valued at approximately $1.1 billion in cash and 31 million shares of stock. This acquisition allows AeroCare’s shareholders, including management and private investors, to become shareholders of AdaptHealth. AeroCare provides home medical equipment and services to over 1 million patients annually, showcasing 20 years of consecutive revenue growth. The merger is anticipated to enhance operational efficiencies and market leadership in the healthcare sector, addressing the needs of chronically ill patients.
AdaptHealth Corp. (NASDAQ: AHCO) has completed its acquisition of AeroCare Holdings Inc. for approximately $1.1 billion in cash and stock, enhancing its home healthcare services. The deal includes 31 million shares of AdaptHealth common stock, subject to shareholder approval. This acquisition enables AdaptHealth to reach nearly 3 million patients across 46 states through over 500 locations. The company will be co-led by AdaptHealth CEO Luke McGee and AeroCare CEO Steve Griggs while expanding its Board of Directors. The transaction was funded through senior notes and credit facility adjustments.
AdaptHealth Corp. (NASDAQ: AHCO) is set to present at the 39th Annual J.P. Morgan Healthcare Conference on January 14, 2021, at 10:00 am EST. The conference runs from January 11-14, 2021, and will be conducted virtually. Interested parties can access a live webcast and replay via the Investors section on www.adapthealth.com. AdaptHealth is a prominent provider of home medical equipment and services, catering to over 1.8 million patients annually across the U.S. through its network of 269 locations.
AdaptHealth Corp. (NASDAQ: AHCO) has priced its public offering of 8,000,000 shares of Class A Common Stock at $33.00 per share, aiming for gross proceeds of approximately $239.25 million. The offering includes 7,250,000 shares from the Company and 750,000 from a selling stockholder, with a 30-day option for underwriters to purchase an additional 1,200,000 shares. Proceeds will fund the acquisition of AeroCare Holdings, Inc. and general corporate purposes. The offering is set to close on January 8, 2021, pending customary conditions.
AdaptHealth Corp. (NASDAQ: AHCO) has initiated a public offering of 7,000,000 shares of its Class A Common Stock, with an additional 1,000,000 shares offered by certain selling stockholders. The offering may also include a 30-day option for underwriters to purchase up to 1,200,000 additional shares. Proceeds will primarily finance the acquisition of AeroCare Holdings, with the remainder allocated for general corporate purposes. The company will not gain any proceeds from shares sold by selling stockholders, and the offering's completion is independent of the AeroCare acquisition.
FAQ
What is the current stock price of AdaptHealth (AHCO)?
What is the market cap of AdaptHealth (AHCO)?
What services does AdaptHealth Corp. provide?
Where does AdaptHealth operate?
What is included in AdaptHealth’s sleep therapy services?
How does AdaptHealth assist patients with diabetes?
What recent financial performance has AdaptHealth reported?
Who is the current CEO of AdaptHealth Corp.?
What kind of equipment does AdaptHealth provide for respiratory therapy?
How does AdaptHealth support wound care?
What partnerships does AdaptHealth have?
How can investors get more information about AdaptHealth?
